Australia markets closed

Nautilus Biotechnology, Inc. (NAUT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3400+0.0600 (+2.63%)
At close: 04:00PM EDT
2.3399 -0.00 (-0.00%)
After hours: 04:05PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-67,440
-63,675
-57,924
-50,315
-15,619
Depreciation & amortisation
6,125
5,705
3,416
2,842
2,346
Stock-based compensation
12,391
12,137
10,380
7,934
369
Change in working capital
-3,788
-3,219
-788
-22
-1,387
Accounts payable
434
393
-561
1,261
123
Other working capital
-57,850
-54,153
-48,130
-41,510
-14,917
Net cash provided by operating activities
-55,453
-51,711
-45,806
-39,241
-13,996
Cash flows from investing activities
Investments in property, plant and equipment
-2,397
-2,442
-2,324
-2,269
-921
Purchases of investments
-85,840
-112,892
-186,591
-221,795
-68,359
Sales/maturities of investments
80,350
71,599
163,175
85,100
44,001
Net cash used for investing activities
-7,887
-43,735
-25,740
-138,964
-25,279
Cash flows from financing activities
Other financing activities
-
-
-
327,280
-
Net cash used provided by (used for) financing activities
612
368
562
327,447
75,899
Net change in cash
-62,728
-95,078
-70,984
149,242
36,624
Cash at beginning of period
89,459
115,477
186,461
37,219
595
Cash at end of period
26,731
20,399
115,477
186,461
37,219
Free cash flow
Operating cash flow
-55,453
-51,711
-45,806
-39,241
-13,996
Capital expenditure
-2,397
-2,442
-2,324
-2,269
-921
Free cash flow
-57,850
-54,153
-48,130
-41,510
-14,917